U.S. markets close in 3 hours 13 minutes
  • S&P 500

    3,945.38
    -53.46 (-1.34%)
     
  • Dow 30

    33,632.77
    -314.33 (-0.93%)
     
  • Nasdaq

    11,044.84
    -195.10 (-1.74%)
     
  • Russell 2000

    1,817.02
    -23.20 (-1.26%)
     
  • Crude Oil

    74.15
    -2.78 (-3.61%)
     
  • Gold

    1,783.40
    +2.10 (+0.12%)
     
  • Silver

    22.36
    -0.06 (-0.25%)
     
  • EUR/USD

    1.0489
    -0.0009 (-0.08%)
     
  • 10-Yr Bond

    3.5680
    -0.0310 (-0.86%)
     
  • GBP/USD

    1.2185
    -0.0009 (-0.08%)
     
  • USD/JPY

    136.7740
    +0.0890 (+0.07%)
     
  • BTC-USD

    16,977.30
    -114.52 (-0.67%)
     
  • CMC Crypto 200

    400.04
    -1.76 (-0.44%)
     
  • FTSE 100

    7,521.39
    -46.15 (-0.61%)
     
  • Nikkei 225

    27,885.87
    +65.47 (+0.24%)
     

The Zacks Analyst Blog Highlights Comcast, Intuit, Boston Scientific, Freeport-McMoRan and Autodesk

For Immediate Release

Chicago, IL – November 11, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Comcast Corp. CMCSA, Intuit Inc. INTU, Boston Scientific Corp. BSX, Freeport-McMoRan Inc. FCX and Autodesk, Inc. ADSK.

Here are highlights from Thursday’s Analyst Blog:

Top Research Reports for Comcast, Intuit and Boston Scientific

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Comcast Corp., Intuit Inc. and Boston Scientific Corp. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Shares of Comcast have declined -41.5% over the past year against the Zacks Cable Television industry’s decline of -44.4%. The company is facing slower broadband user base addition primarily due to reversal of pandemic trends and increased competition from fixed wireless as well as fiber are concerns.

It is also persistently suffering from video-subscriber attrition due to cord cutting. Moreover, a leveraged balance sheet is also a major concern. Nevertheless, Comcast’s plan to transition to DOCSIS 4.0 is noteworthy. The technology will help the company in expanding much faster and at a lower cost compared to competitors.

Recovery in park and movie business bodes well for Comcast’s profitability. Its streaming service Peacock is a key catalyst in driving broadband sales. Strong free cash flow generation ability is noteworthy.

(You can read the full research report on Comcast here >>>)

Shares of Intuit have modestly underperformed the Zacks Computer - Software industry over the past year (-39.3% vs. -35.2%). The company is facing macroeconomic and geopolitical headwinds which might significantly hurt small businesses operations, thereby posing risks for Intuit’s top-line growth. Additionally, higher costs and expenses due to increased investments in marketing and engineering teams are likely to continue impacting bottom-line results in the near term.

However, Intuit is benefiting from strong momentum in online ecosystem revenues and solid professional tax revenues. The TurboTax Live offering is also driving growth in the Consumer tax business. Solid momentum in the company’s lending product, QuickBooks Capital, remains a positive.

Moreover, the company’s strategy of shifting its business to cloud-based subscription model will help generate stable revenues over the long run. The Zacks analyst expect Intuit’s revenues to grow at a CAGR of 14.66% through fiscal 2023-2025.

(You can read the full research report on Intuit here >>>)

Boston Scientific shares have outperformed the Zacks Medical - Products industry over the past year (+0.2% vs. -50.0%). The company registered a year-over-year improvement in organic sales, indicating a strong rebound in the legacy business from the pandemic mayhem. Organic revenues at each of its core business and geographies were up.

The raised 2022 organic revenue guidance looks promising. Over the past year, Boston Scientific outperformed its industry. However, mounting costs and expenses are putting pressure on the company’s margins.

The ongoing macro-environment challenges related to increasing freight costs and higher direct labor wages continue to hamper business. Unfavorable foreign exchange deters growth. The upper end of the full-year adjusted EPS guidance has been reduced increasing concerns.

(You can read the full research report on Boston Scientific here >>>)

Other noteworthy reports we are featuring today include Freeport-McMoRan Inc. and Autodesk, Inc.

Why Haven’t You Looked at Zacks' Top Stocks?

Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Boston Scientific Corporation (BSX) : Free Stock Analysis Report
 
Comcast Corporation (CMCSA) : Free Stock Analysis Report
 
FreeportMcMoRan Inc. (FCX) : Free Stock Analysis Report
 
Autodesk, Inc. (ADSK) : Free Stock Analysis Report
 
Intuit Inc. (INTU) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research